Chapter 6 – Nanotechnology safety in the biomedical industry
Citation
Charles C. Blatchley, Chapter 6 - Nanotechnology Safety in the Biomedical Industry, In: R. Asmatulu, Editor(s), Nanotechnology Safety, Elsevier, Amsterdam, 2013, Pages 73-83, ISBN 9780444594389, http://dx.doi.org/10.1016/B978-0-444-59438-9.00006-0.
Abstract
Nanomaterials are of interest in many biomedical applications for potential enhancements in structural strength of bone implants, controlled drug release, improved chemical interactions, and scaffolding for cell in-growth and tissue replacement. Unfortunately, the key changes in material properties that enhance performance seem to lead in some cases to increased toxicity. By shifting the distribution of wear particle sizes to smaller individual particles, adverse effects may be created, either directly from the nanoparticle interactions or through intermediary species, such as reactive oxygen. Either way, biological activity often seems to be dependent on particle size, and deleterious side effects and workplace hazards must be evaluated and avoided.
Table of Content
Description
Click on the DOI link to access this book chapter (may not be free)